Critical Care Explorations最新文献

{"title":"A Wireless, Wearable Carotid Doppler Ultrasound Aids Diagnosis and Monitoring of Pericardial Tamponade: A Case Report.","authors":"Ross Prager,&nbsp;Michael Pratte,&nbsp;Jon-Emile Kenny,&nbsp;Philippe Rola","doi":"10.1097/CCE.0000000000000911","DOIUrl":"10.1097/CCE.0000000000000911","url":null,"abstract":"<p><p>Pericardial tamponade can often be diagnosed through clinical findings and echocardiography; however, the diagnosis can be aided by demonstrating the hemodynamic consequences of the effusion. We describe the use of a wearable carotid Doppler device to help diagnose and monitor pericardial tamponade.</p><p><strong>Case summary: </strong>A 54-year-old man developed hypotension after an endobronchial biopsy for a lung mass. Echocardiography showed a pericardial effusion with sonographic evidence of tamponade. A wearable carotid Doppler device demonstrated low corrected carotid flow time (CFT) (a surrogate for stroke volume) with significant respiratory variation, supporting the diagnosis of tamponade. The patient underwent pericardiocentesis which revealed purulent pericardial fluid from a mediastinal abscess. After drainage there was increased CFT and reduced respiratory variability in Doppler, surrogates of improved stroke volume.</p><p><strong>Conclusion: </strong>A wearable carotid Doppler device is a noninvasive tool that can help determine the hemodynamic impact of a pericardial effusion, and potentially aid in the diagnosis of pericardial tamponade.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0911"},"PeriodicalIF":0.0,"publicationDate":"2023-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/37/16/cc9-5-e0911.PMC10168526.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Digital Health Strategy to Support Clinician-Led Critically Ill Patient Population Management: A Randomized Crossover Study.","authors":"Svetlana Herasevich,&nbsp;Yuliya Pinevich,&nbsp;Kirill Lipatov,&nbsp;Amelia K Barwise,&nbsp;Heidi L Lindroth,&nbsp;Allison M LeMahieu,&nbsp;Yue Dong,&nbsp;Vitaly Herasevich,&nbsp;Brian W Pickering","doi":"10.1097/CCE.0000000000000909","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000909","url":null,"abstract":"<p><p>To investigate whether a novel acute care multipatient viewer (AMP), created with an understanding of clinician information and process requirements, could reduce time to clinical decision-making among clinicians caring for populations of acutely ill patients compared with a widely used commercial electronic medical record (EMR).</p><p><strong>Design: </strong>Single center randomized crossover study.</p><p><strong>Setting: </strong>Quaternary care academic hospital.</p><p><strong>Subjects: </strong>Attending and in-training critical care physicians, and advanced practice providers.</p><p><strong>Interventions: </strong>AMP.</p><p><strong>Measurements and main results: </strong>We compared ICU clinician performance in structured clinical task completion using two electronic environments-the standard commercial EMR (Epic) versus the novel AMP in addition to Epic. Twenty subjects (10 pairs of clinicians) participated in the study. During the study session, each participant completed the tasks on two ICUs (7-10 beds each) and eight individual patients. The adjusted time for assessment of the entire ICU and the adjusted total time to task completion were significantly lower using AMP versus standard commercial EMR (-6.11; 95% CI, -7.91 to -4.30 min and -5.38; 95% CI, -7.56 to -3.20 min, respectively; <i>p</i> < 0.001). The adjusted time for assessment of individual patients was similar using both the EMR and AMP (0.73; 95% CI, -0.09 to 1.54 min; <i>p</i> = 0.078). AMP was associated with a significantly lower adjusted task load (National Aeronautics and Space Administration-Task Load Index) among clinicians performing the task versus the standard EMR (22.6; 95% CI, -32.7 to -12.4 points; <i>p</i> < 0.001). There was no statistically significant difference in adjusted total errors when comparing the two environments (0.68; 95% CI, 0.36-1.30; <i>p</i> = 0.078).</p><p><strong>Conclusions: </strong>When compared with the standard EMR, AMP significantly reduced time to assessment of an entire ICU, total time to clinical task completion, and clinician task load. Additional research is needed to assess the clinicians' performance while using AMP in the live ICU setting.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0909"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/07/cc9-5-e0909.PMC10158897.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9782997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Association Between Time From Emergency Department Visit to ICU Admission and Mortality in Patients With Sepsis.","authors":"Junichiro Shibata,&nbsp;Itsuki Osawa,&nbsp;Kiyoyasu Fukuchi,&nbsp;Tadahiro Goto","doi":"10.1097/CCE.0000000000000915","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000915","url":null,"abstract":"<p><p>The Surviving Sepsis Campaign Guidelines 2021 recommends that adult patients with sepsis requiring intensive care should be admitted to the ICU within 6 hours of their emergency department (ED) visits. However, there is limited evidence on whether 6 hours is the best target time for compliance with the sepsis bundle. We aimed to investigate the association between time from ED visits to ICU admission (i.e., ED length of stay [ED-LOS]) and mortality and identify the optimal ED-LOS for patients with sepsis.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>The Medical Information Mart for Intensive Care Emergency Department and Medical Information Mart for Intensive Care IV databases.</p><p><strong>Patients: </strong>Adult patients (≥ 18 yr old) who were transferred from the ED to the ICU and subsequently diagnosed with sepsis based on the Sepsis-3 criteria within 24 hours of ICU admission.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>Among 1,849 patients with sepsis, we found a disproportionally higher mortality rate in patients immediately admitted to the ICU (e.g., < 2 hr). When using ED-LOS as a continuous variable, ED-LOS was not significantly associated with 28-day mortality (adjusted odds ratio [OR] per hour increase, 1.04; 95% CI, 0.96-1.13; <i>p</i> = 0.3) after an adjustment for potential confounders (e.g., demographics, triage vital signs, and laboratory results) in the multivariable analysis. However, when we categorized all patients into time quartiles (ED-LOS: < 3.3 hr, 3.3-4.5 hr, 4.6-6.1 hr, and > 6.1 hr), patients in the higher time quartiles (e.g., 3.3-4.5 hr) had higher 28-day mortality compared with those in the lowest time quartile (< 3.3 hr) (e.g., adjusted OR for patients in the second time quartile [3.3-4.5 hr] 1.59; 95% CI, 1.03-2.46; <i>p</i> = 0.04).</p><p><strong>Conclusions: </strong>Earlier admission to the ICU (e.g., within 3.3 hr of ED visits) was associated with lower 28-day mortality in patients with sepsis. Our findings suggest patients with sepsis who require intensive care may benefit from a more immediate ICU admission than 6 hours.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0915"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/8c/cc9-5-e0915.PMC10171575.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9470405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lung Abscess and Pyothorax in Critically Ill COVID-19 Patients: A Single-Center Retrospective Study.","authors":"Shu Utsumi,&nbsp;Shinichiro Ohshimo,&nbsp;Junki Ishii,&nbsp;Mitsuaki Nishikimi,&nbsp;Nobuaki Shime","doi":"10.1097/CCE.0000000000000919","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000919","url":null,"abstract":"<p><p>The mortality rate of patients with COVID-19 pneumonia requiring mechanical ventilation remains high. This study determined the percentage and characteristics of patients who developed lung abscesses or pyothorax and their mortality rates among adult patients with COVID-19 admitted to the ICU who required mechanical ventilation. Of the 64 patients with COVID-19 assessed, 30 (47%) developed ventilator-associated pneumonia (VAP), of whom 6 (20%) developed pyothorax or lung abscess. There were no statistically significant differences in patient characteristics, treatment after ICU admission, or outcomes between those with and without these complications, except for age. VAP complicated by Lung abscess or pyothorax was caused by a single organism, with <i>Staphylococcus aureus (n</i> = 4) and <i>Klebsiella</i> species (<i>n</i> = 2) being the primary causative agents. Occur infrequently in patients with COVID-19 requiring mechanical ventilation. Large-scale studies are required to elucidate their effects on clinical outcomes.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0919"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/1c/cc9-5-e0919.PMC10184985.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9487455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Heart Rate Change as a Potential Digital Biomarker of Brain Death in Critically Ill Children With Acute Catastrophic Brain Injury.","authors":"Kerri L LaRovere,&nbsp;Matthew Luchette,&nbsp;Alireza Akhondi-Asl,&nbsp;Bradley J DeSouza,&nbsp;Robert C Tasker,&nbsp;Nilesh M Mehta,&nbsp;Alon Geva","doi":"10.1097/CCE.0000000000000908","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000908","url":null,"abstract":"<p><p>Bedside measurement of heart rate (HR) change (HRC) may provide an objective physiologic marker for when brain death (BD) may have occurred, and BD testing is indicated in children.</p><p><strong>Objectives: </strong>To determine whether HRC, calculated using numeric HR measurements sampled every 5 seconds, can identify patients with BD among patients with catastrophic brain injury (CBI).</p><p><strong>Design setting and participants: </strong>Single-center, retrospective study (2008-2020) of critically ill children with acute CBI. Patients with CBI had a neurocritical care consultation, were admitted to an ICU, had acute neurologic injury on presentation or during hospitalization based on clinical and/or imaging findings, and died or survived with Glasgow Coma Scale (GCS) less than 13 at hospital discharge. Patients meeting BD criteria (BD group) were compared with those with cardiopulmonary death (CD group) or those who survived to discharge.</p><p><strong>Main outcomes and measures: </strong>HRC was calculated as the interquartile range of HR divided by median HR using 5-minute windows with 50% overlap for up to 5 days before death or end of recording. HRC was compared among the BD, CD, and survivor groups.</p><p><strong>Results: </strong>Of 96 patients with CBI (69% male, median age 4 years), 28 died (8 BD, 20 CD) and 20 survived (median GCS 9 at discharge). Within 24 hours before death, HRC was lower in BD compared with CD patients or survivors (0.01 vs 0.03 vs 0.04, <i>p</i> = 0.001). In BD patients, HRC decreased at least 1 day before death. HRC discriminated BD from CD patients and survivors with 90% sensitivity, 70% specificity, 44% positive predictive value, 96% negative predictive value (area under the receiver operating characteristic curve 0.88, 95% CI, 0.80-0.93).</p><p><strong>Conclusions and relevance: </strong>HRC is a novel digital biomarker that, with further validation, may be useful as a classifier for BD in the overall course of patients with CBI.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0908"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/5b/cc9-5-e0908.PMC10158912.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9782996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Order Set Usage is Associated With Lower Hospital Mortality in Patients With Sepsis.","authors":"Christopher R Dale,&nbsp;Shelley Schoepflin Sanders,&nbsp;Shu Ching Chang,&nbsp;Omar Pandhair,&nbsp;Naomi G Diggs,&nbsp;Whitney Woodruff,&nbsp;David N Selander,&nbsp;Nicholas M Mark,&nbsp;Sarah Nurse,&nbsp;Mark Sullivan,&nbsp;Liga Mezaraups,&nbsp;D Shane O'Mahony","doi":"10.1097/CCE.0000000000000918","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000918","url":null,"abstract":"<p><p>The Surviving Sepsis Campaign recommends standard operating procedures for patients with sepsis. Real-world evidence about sepsis order set implementation is limited.</p><p><strong>Objectives: </strong>To estimate the effect of sepsis order set usage on hospital mortality.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting and participants: </strong>Fifty-four acute care hospitals in the United States from December 1, 2020 to November 30, 2022 involving 104,662 patients hospitalized for sepsis.</p><p><strong>Main outcomes and measures: </strong>Hospital mortality.</p><p><strong>Results: </strong>The sepsis order set was used in 58,091 (55.5%) patients with sepsis. Initial mean sequential organ failure assessment score was 0.3 lower in patients for whom the order set was used than in those for whom it was not used (2.9 sd [2.8] vs 3.2 [3.1], <i>p</i> < 0.01). In bivariate analysis, hospital mortality was 6.3% lower in patients for whom the sepsis order set was used (9.7% vs 16.0%, <i>p</i> < 0.01), median time from emergency department triage to antibiotics was 54 minutes less (125 interquartile range [IQR, 68-221] vs 179 [98-379], <i>p</i> < 0.01), and median total time hypotensive was 2.1 hours less (5.5 IQR [2.0-15.0] vs 7.6 [2.5-21.8], <i>p</i> < 0.01) and septic shock was 3.2% less common (22.0% vs 25.4%, <i>p</i> < 0.01). Order set use was associated with 1.1 fewer median days of hospitalization (4.9 [2.8-9.0] vs 6.0 [3.2-12.1], <i>p</i> < 0.01), and 6.6% more patients discharged to home (61.4% vs 54.8%, <i>p</i> < 0.01). In the multivariable model, sepsis order set use was independently associated with lower hospital mortality (odds ratio 0.70; 95% CI, 0.66-0.73).</p><p><strong>Conclusions and relevance: </strong>In a cohort of patients hospitalized with sepsis, order set use was independently associated with lower hospital mortality. Order sets can impact large-scale quality improvement efforts.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0918"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/58/cc9-5-e0918.PMC10191554.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9852334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of Epileptiform Activity With Outcomes in Toxic-Metabolic Encephalopathy.","authors":"Patrick M Chen,&nbsp;Sophie Schuurmans Stekhoven,&nbsp;Adnan Haider,&nbsp;Jin Jing,&nbsp;Wendong Ge,&nbsp;Eric S Rosenthal,&nbsp;M Brandon Westover,&nbsp;Sahar F Zafar","doi":"10.1097/CCE.0000000000000913","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000913","url":null,"abstract":"<p><p>The clinical significance of epileptiform abnormalities (EAs) specific to toxic-metabolic encephalopathy (TME) is unknown.</p><p><strong>Objectives: </strong>To quantify EA burden in patients with TME and its association with neurologic outcomes.</p><p><strong>Design setting and participant: </strong>This is a retrospective study. A cohort of patients with TME and EA (positive) were age, Sequential Organ Failure Assessment Score, Acute Physiology and Chronic Health Evaluation II (APACHE-II) score matched to a cohort of TME patients without EA (control). Univariate analysis compared EA-positive patients against controls. Multivariable logistical regression adjusting for underlying disease etiology was performed to examine the relationship between EA burden and probability of poor neurologic outcome (modified Rankin Score [mRS] 4-6) at discharge. Consecutive admissions to inpatient floors or ICUs that underwent continuous electroencephalography (cEEG) monitoring at a single center between 2012 and 2019. Inclusion criteria were 1) patients with TME diagnosis, 2) age greater than 18 years, and 3) greater than or equal to 16 hours of cEEG. Patients with acute brain injury and cardiac arrest were excluded.</p><p><strong>Main outcomes and measures: </strong>Poor neurologic outcome defined by mRS (mRS 4-6).</p><p><strong>Results: </strong>One hundred sixteen patients were included, 58 with EA and 58 controls without EA, where matching was performed on age and APACHE-II score. The median age was 66 (Q1-Q3, 57-75) and median APACHE II score was 18 (Q1-Q3, 13-22). Overall cohort discharge mortality was 22% and 70% had a poor neurologic outcome. Peak EA burden was defined as the 12-hour window of recording with the highest prevalence of EAs. In multivariable analysis adjusted for Charlson Comorbidity Index and primary diagnosis, presence of EAs was associated with poor outcome (odds ratio 3.89; CI [1.05-14.2], <i>p</i> = 0.041). Increase in peak EA burden from 0% to 100% increased probability of poor discharge neurologic outcome by 30%.</p><p><strong>Conclusions and relevance: </strong>Increasing burden of EA is associated with worse discharge outcomes in patients with TME. Future studies are needed to determine whether short-term treatment with anti-seizure medications while medically treating the underlying metabolic derangement improves outcomes.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0913"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5d/da/cc9-5-e0913.PMC10166342.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9446588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing and Validating a Prediction Model For Death or Critical Illness in Hospitalized Adults, an Opportunity for Human-Computer Collaboration.","authors":"Amol A Verma,&nbsp;Chloe Pou-Prom,&nbsp;Liam G McCoy,&nbsp;Joshua Murray,&nbsp;Bret Nestor,&nbsp;Shirley Bell,&nbsp;Ophyr Mourad,&nbsp;Michael Fralick,&nbsp;Jan Friedrich,&nbsp;Marzyeh Ghassemi,&nbsp;Muhammad Mamdani","doi":"10.1097/CCE.0000000000000897","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000897","url":null,"abstract":"<p><p>Hospital early warning systems that use machine learning (ML) to predict clinical deterioration are increasingly being used to aid clinical decision-making. However, it is not known how ML predictions complement physician and nurse judgment. Our objective was to train and validate a ML model to predict patient deterioration and compare model predictions with real-world physician and nurse predictions.</p><p><strong>Design: </strong>Retrospective and prospective cohort study.</p><p><strong>Setting: </strong>Academic tertiary care hospital.</p><p><strong>Patients: </strong>Adult general internal medicine hospitalizations.</p><p><strong>Measurements and main results: </strong>We developed and validated a neural network model to predict in-hospital death and ICU admission in 23,528 hospitalizations between April 2011 and April 2019. We then compared model predictions with 3,374 prospectively collected predictions from nurses, residents, and attending physicians about their own patients in 960 hospitalizations between April 30, and August 28, 2019. ML model predictions achieved clinician-level accuracy for predicting ICU admission or death (ML median F1 score 0.32 [interquartile range (IQR) 0.30-0.34], AUC 0.77 [IQ 0.76-0.78]; clinicians median F1-score 0.33 [IQR 0.30-0.35], AUC 0.64 [IQR 0.63-0.66]). ML predictions were more accurate than clinicians for ICU admission. Of all ICU admissions and deaths, 36% occurred in hospitalizations where the model and clinicians disagreed. Combining human and model predictions detected 49% of clinical deterioration events, improving sensitivity by 16% compared with clinicians alone and 24% compared with the model alone while maintaining a positive predictive value of 33%, thus keeping false alarms at a clinically acceptable level.</p><p><strong>Conclusions: </strong>ML models can complement clinician judgment to predict clinical deterioration in hospital. These findings demonstrate important opportunities for human-computer collaboration to improve prognostication and personalized medicine in hospital.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0897"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1e/5c/cc9-5-e0897.PMC10155889.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9485171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Therapeutic Effect of Argatroban During Cardiopulmonary Resuscitation and Streptokinase During Extracorporeal Cardiopulmonary Resuscitation in a Porcine Model of Prolonged Cardiac Arrest.","authors":"Jensyn J VanZalen,&nbsp;Stephen Harvey,&nbsp;Pavel Hála,&nbsp;Annie Phillips,&nbsp;Takahiro Nakashima,&nbsp;Emre Gok,&nbsp;Mohamad Hakam Tiba,&nbsp;Brendan M McCracken,&nbsp;Joseph E Hill,&nbsp;Jinhui Liao,&nbsp;Joshua Jung,&nbsp;Joshua Mergos,&nbsp;William C Stacey,&nbsp;Robert H Bartlett,&nbsp;Cindy H Hsu,&nbsp;Alvaro Rojas-Peña,&nbsp;Robert W Neumar","doi":"10.1097/CCE.0000000000000902","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000902","url":null,"abstract":"<p><p>Prolonged cardiac arrest (CA) causes microvascular thrombosis which is a potential barrier to organ reperfusion during extracorporeal cardiopulmonary resuscitation (ECPR). The aim of this study was to test the hypothesis that early intra-arrest anticoagulation during cardiopulmonary resuscitation (CPR) and thrombolytic therapy during ECPR improve recovery of brain and heart function in a porcine model of prolonged out-of-hospital CA.</p><p><strong>Design: </strong>Randomized interventional trial.</p><p><strong>Setting: </strong>University laboratory.</p><p><strong>Subjects: </strong>Swine.</p><p><strong>Interventions: </strong>In a blinded study, 48 swine were subjected to 8 minutes of ventricular fibrillation CA followed by 30 minutes of goal-directed CPR and 8 hours of ECPR. Animals were randomized into four groups (<i>n</i> = 12) and given either placebo (P) or argatroban (ARG; 350 mg/kg) at minute 12 of CA and either placebo (P) or streptokinase (STK, 1.5 MU) at the onset of ECPR.</p><p><strong>Measurements and main results: </strong>Primary outcomes included recovery of cardiac function measured by cardiac resuscitability score (CRS: range 0-6) and recovery of brain function measured by the recovery of somatosensory-evoked potential (SSEP) cortical response amplitude. There were no significant differences in recovery of cardiac function as measured by CRS between groups (<i>p</i> = 0.16): P + P 2.3 (1.0); ARG + P = 3.4 (2.1); P + STK = 1.6 (2.0); ARG + STK = 2.9 (2.1). There were no significant differences in the maximum recovery of SSEP cortical response relative to baseline between groups (<i>p</i> = 0.73): P + P = 23% (13%); ARG + P = 20% (13%); P + STK = 25% (14%); ARG + STK = 26% (13%). Histologic analysis demonstrated reduced myocardial necrosis and neurodegeneration in the ARG + STK group relative to the P + P group.</p><p><strong>Conclusions: </strong>In this swine model of prolonged CA treated with ECPR, early intra-arrest anticoagulation during goal-directed CPR and thrombolytic therapy during ECPR did not improve initial recovery of heart and brain function but did reduce histologic evidence of ischemic injury. The impact of this therapeutic strategy on the long-term recovery of cardiovascular and neurological function requires further investigation.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0902"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/fa/cc9-5-e0902.PMC10174369.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9473942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detecting the Change in Total Circulatory Flow with a Wireless, Wearable Doppler Ultrasound Patch: A Pilot Study.","authors":"Chelsea E Munding,&nbsp;Jon-Émile S Kenny,&nbsp;Zhen Yang,&nbsp;Geoffrey Clarke,&nbsp;Mai Elfarnawany,&nbsp;Andrew M Eibl,&nbsp;Joseph K Eibl,&nbsp;Bhanu Nalla,&nbsp;Rony Atoui","doi":"10.1097/CCE.0000000000000914","DOIUrl":"https://doi.org/10.1097/CCE.0000000000000914","url":null,"abstract":"<p><p>Measuring fluid responsiveness is important in the management of critically ill patients, with a 10-15% change in cardiac output typically being used to indicate \"fluid responsiveness.\" Ideally, these changes would be measured noninvasively and peripherally. The aim of this study was to determine how the common carotid artery (CCA) maximum velocity changes with total circulatory flow when confounding factors are mitigated and determine a value for CCA maximum velocity corresponding to a 10% change in total circulatory flow.</p><p><strong>Design: </strong>Prospective observational pilot study.</p><p><strong>Setting: </strong>Patients undergoing elective, on-pump coronary artery bypass grafting (CABG) surgery.</p><p><strong>Patients: </strong>Fourteen patients were referred for elective coronary artery bypass grafting surgery.</p><p><strong>Interventions: </strong>Cardiopulmonary bypass (CPB) pump flow changes during surgery, as chosen by the perfusionist.</p><p><strong>Measurements: </strong>A hands-free, wearable Doppler patch was used for CCA velocity measurements with the aim of preventing user errors in ultrasound measurements. Maximum CCA velocity was determined from the spectrogram acquired by the Doppler patch. CPB flow rates were recorded as displayed on the CPB console, and further measured from the peristaltic pulsation frequency visible on the recorded Doppler spectrograms.</p><p><strong>Main results: </strong>Changes in CCA maximum velocity tracked well with changes in CPB flow. On average, a 13.6% change in CCA maximum velocity was found to correspond to a 10% change in CPB flow rate.</p><p><strong>Conclusions: </strong>Changes in CCA velocity may be a useful surrogate for determining fluid responsiveness when user error can be mitigated.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0914"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/5f/cc9-5-e0914.PMC10166367.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9446590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}